BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4008307)

  • 1. Thrombocytopenia associated with vaccination of a dog with a modified-live paramyxovirus vaccine.
    McAnulty JF; Rudd RG
    J Am Vet Med Assoc; 1985 Jun; 186(11):1217-9. PubMed ID: 4008307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole reduces the thrombocytopenia associated with myxovirus vaccination.
    Pineau S; Belbeck LW; Moore S
    Can Vet J; 1980 Mar; 21(3):82-4. PubMed ID: 7363270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with canine distemper vaccines in exotic carnivores.
    Montali RJ; Bartz CR; Teare JA; Allen JT; Appel MJ; Bush M
    J Am Vet Med Assoc; 1983 Dec; 183(11):1163-7. PubMed ID: 6358163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of gray foxes to modified live-virus canine distemper vaccines.
    Halbrooks RD; Swango LJ; Schnurrenberger PR; Mitchell FE; Hill EP
    J Am Vet Med Assoc; 1981 Dec; 179(11):1170-4. PubMed ID: 7199036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine.
    Krakowka S; Olsen RG; Axthelm MK; Rice J; Winters K
    J Am Vet Med Assoc; 1982 Jan; 180(2):137-9. PubMed ID: 7061309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vaccination with recombinant canine distemper virus vaccine immediately before exposure under shelter-like conditions.
    Larson LJ; Schultz RD
    Vet Ther; 2006; 7(2):113-8. PubMed ID: 16871493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination-induced distemper in kinkajous.
    Kazacos KR; Thacker HL; Shivaprasad HL; Burger PP
    J Am Vet Med Assoc; 1981 Dec; 179(11):1166-9. PubMed ID: 7199035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field evaluation of a canine parvovirus vaccination program, using feline origin modified live virus vaccine.
    Gordon JC; Rogers WA
    J Am Vet Med Assoc; 1982 Jun; 180(12):1429-31. PubMed ID: 6284689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus.
    Pollock RV; Carmichael LE
    Am J Vet Res; 1983 Feb; 44(2):169-75. PubMed ID: 6299142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-induced canine distemper in European mink, Mustela lutreola.
    Sutherland-Smith MR; Rideout BA; Mikolon AB; Appel MJ; Morris PJ; Shima AL; Janssen DJ
    J Zoo Wildl Med; 1997 Sep; 28(3):312-8. PubMed ID: 9365945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a modified live, canine origin parvovirus vaccine.
    Bass EP; Gill MA; Beckenhauer WH
    J Am Vet Med Assoc; 1982 Nov; 181(9):909-13. PubMed ID: 7141990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questions wisdom of using modified-live virus vaccines as boosters.
    Craige JE
    J Am Vet Med Assoc; 1990 Aug; 197(3):297-8. PubMed ID: 2391261
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease in platelet count after vaccination with distemper-hepatitis (DH) vaccine.
    Straw B
    Vet Med Small Anim Clin; 1978 Jun; 73(6):725-6. PubMed ID: 211690
    [No Abstract]   [Full Text] [Related]  

  • 18. Distemper-like disease and encephalitozoonosis in wild dogs (Lycaon pictus).
    Van Heerden J; Bainbridge N; Burroughs RE; Kriek NP
    J Wildl Dis; 1989 Jan; 25(1):70-5. PubMed ID: 2492610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined viral and bacterial antigens for canine vaccines.
    York CJ
    J Am Vet Med Assoc; 1966 Sep; 149(5):681-5. PubMed ID: 4291220
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
    Pardo MC; Bauman JE; Mackowiak M
    Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.